The Company's request
Tate and Lyle have requested approval to market a new sweetener, sucralose, in the UK. In line with the provisions of the relevant European legislation, the approval would be for a period of two years pending consideration by the European Commission of the company's application for EU wide approval of the product (see paragraph 4 below). Sucralose is manufactured by controlled chlorination of sucrose and is approximately 500-600 times sweeter than sugar. It is currently approved in several other countries world-wide, including Canada (since 1991), Australia (1993) and the US (1998/99).
The company's technological justification is available. The list of food categories for which the company is seeking approval to use sucralose, together with proposed usage limits is also available from the FSA web pages. Approval would also allow sucralose to be used in tabletop sweetener products.
The relevant legislation for the approval of sweeteners within the EU is as follows:
Article 5 of the Food Additives Framework Directive permits Member States to provisionally authorise the marketing and use of an additive within its territory which is not included in the relevant list (i.e. are not included in the list of permitted additives in the relevant directive). Such authorisation is permitted for a maximum of two years, during which time the applicant is required to seek EU-wide approval. The Member State must also ensure that foodstuffs containing the additive are officially monitored.
Towards the end of 2000 Tate and Lyle also applied for approval of sucralose on an EU-wide basis. The European Commission's Scientific Committee on Food (SCF) has carried out a safety assessment of the sweetener (see below) and the Commission has already taken the first steps towards issuing a formal proposal for various amendments to the EC Sweeteners Directive, including the addition of sucralose to the list of approved sweeteners. However, the process for legal adoption of these amendments is complex and the timetable for completion is uncertain. We are also informed that the German authorities have recently granted national authorisation for the use of sucralose in a tabletop sweetener product.
The SCF is the independent scientific committee which advises the European Commission on questions concerning consumer health and food safety. It has assessed the data on the safety of sucralose and issued its opinion in September 2000. This concluded: 'that sucralose is acceptable as a sweetener for general food use and that a full Acceptable Daily Intake level (ADI) of 0-15mg/kg body weight can be established'. This was in line with the ADI set for sucralose by the Joint FAO/WHO Expert Committee on Food Additives in 1990. Copies of the full SCF opinion are available from the SCF website at www.europa.eu.int/comm/dg24/health/sc/scf/outcome_en.html
In the UK the Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment (COT) is the independent expert committee which advises the UK government on food safety issues relevant to the use of additives. The COT has endorsed the SCF opinion on sucralose and the Food Standards Agency has concluded that it is unnecessary to carry out a further separate safety assessment of the product.
The Food Additives Framework Directive requires that new additives are approved only where there can be demonstrated a reasonable technological need and where there are demonstrable advantages of benefit to the consumer - commonly referred to as the 'case of need'. Intense sweeteners have benefits for those wishing to reduce their sugar or calorie intake and for diabetics. The manufacturers claim the following specific additional benefits for sucralose when compared with other sweeteners currently available for use by consumers and manufacturers:
At the end of this consultation process the FSA intends to proceed as follows;